Trends in uptake of cancer screening among people with severe mental illness before and after the COVID-19 pandemic in Japan: A repeated cross-sectional study
- PMID: 39902101
- PMCID: PMC11788321
- DOI: 10.1002/pcn5.70062
Trends in uptake of cancer screening among people with severe mental illness before and after the COVID-19 pandemic in Japan: A repeated cross-sectional study
Abstract
Aim: The aim of this study was to investigate trends in cancer screening participation among people with severe mental illness (PSMI) from periods before and after the COVID-19 pandemic.
Methods: In this repeated cross-sectional study, we used anonymized datasets on municipal cancer screening participation among PSMI in Okayama City. The data covered fiscal year (FY) 2018 to FY2022; we used the municipal cancer screening database and Medical Payment for Services and Supports for Persons with Disabilities. PSMI were defined as those with schizophrenia or related psychotic disorders (F20-29) or bipolar disorder (F30 or F31), identified using International Classification of Diseases, Tenth Revision, codes. The analysis included men and women aged 40-69 years for colorectal and lung cancer screening; men and women aged 50-69 years for gastric cancer screening; women aged 40-69 years for breast cancer screening; and women aged 20-69 years for cervical cancer screening. Municipal cancer screening rates among PSMI were calculated for each FY.
Results: For all cancer types, cancer screening rates for PSMI in FY2020 (colorectal: 9.0%; lung: 11.6%; gastric: 4.9%; breast: 6.2%; and cervical: 6.1%) were lower than the rates in FY2019 (11.5%, 14.0%, 6.5%, 9.3%, and 8.3%, respectively). In FY2022, the rates (9.9%, 12.9%; 5.3%; 8.0%, and 6.9%, respectively) recovered, but remained low.
Conclusion: This study showed that cancer screening rates among PSMI were very low, both before and after the COVID-19 pandemic. Efforts to encourage participation in cancer screening in this population are urgently needed.
Keywords: COVID‐19; bipolar disorder; cancer screening; healthcare disparities; schizophrenia.
© 2025 The Author(s). Psychiatry and Clinical Neurosciences Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
Conflict of interest statement
Y. Yamada has received honoraria from Meiji, Sumitomo Pharma, Takeda, and Lundbeck. M. Fujiwara has received honoraria from Mochida and Eisai. K. Otsuki has received honoraria for lectures from Otsuka, Meiji, Sumitomo Pharma, Takeda, Nippon Shinyaku, and Yoshitomiyakuhin. M. Inagaki has received grants from Astellas, Eisai, Otsuka, Shionogi, Daiichi Sankyo, Sumitomo Pharma, Takeda, Mitsubishi Tanabe Pharma, Nihon Medi‐Physics, Pfizer, Fujifilm, and Mochida and has received honoraria for lectures from EA Pharma, Meiji, MSD, Viatris, Eisai, Otsuka, Sumitomo Pharma, Takeda, Eli Lilly, Nippon Shinyaku, Pfizer, Mochida, Janssen and Yoshitomiyakuhin. The other authors declare that they have no competing interests.
Figures

Similar articles
-
Low Cancer Screening Rates among Japanese People with Schizophrenia: A Cross-Sectional Study.Tohoku J Exp Med. 2018 Mar;244(3):209-218. doi: 10.1620/tjem.244.209. Tohoku J Exp Med. 2018. PMID: 29540627
-
The prevalence and factors for cancer screening behavior among people with severe mental illness in Hong Kong.PLoS One. 2014 Sep 30;9(9):e107237. doi: 10.1371/journal.pone.0107237. eCollection 2014. PLoS One. 2014. PMID: 25268752 Free PMC article.
-
Cancer Screening Disparities Before and After the COVID-19 Pandemic.JAMA Netw Open. 2023 Nov 1;6(11):e2343796. doi: 10.1001/jamanetworkopen.2023.43796. JAMA Netw Open. 2023. PMID: 37983033 Free PMC article.
-
Participatory Action Research Among People With Serious Mental Illness: A Scoping Review.Qual Health Res. 2024 Jan;34(1-2):3-19. doi: 10.1177/10497323231208111. Epub 2023 Nov 6. Qual Health Res. 2024. PMID: 37929751 Free PMC article.
-
A rapid review of COVID-19's global impact on breast cancer screening participation rates and volumes from January to December 2020.Elife. 2023 Sep 12;12:e85680. doi: 10.7554/eLife.85680. Elife. 2023. PMID: 37698273 Free PMC article.
References
-
- Solmi M, Firth J, Miola A, Fornaro M, Frison E, Fusar‐Poli P, et al. Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta‐analysis including 4 717 839 people. Lancet Psychiatry. 2020;7:52–63. - PubMed
-
- Shin DW, Lee JW, Jung JH, Han K, Kim SY, Choi KS, et al. Disparities in cervical cancer screening among women with disabilities: a national database study in South Korea. J Clin Oncol. 2018;36:2778–2786. - PubMed
-
- Shin DW, Yu J, Cho J, Lee SK, Jung JH, Han K, et al. Breast cancer screening disparities between women with and without disabilities: a national database study in South Korea. Cancer. 2020;126:1522–1529. - PubMed
-
- Fujiwara M, Higuchi Y, Nakaya N, Fujimori M, Yamada Y, Wada R, et al. Trends in cancer screening rates among individuals with serious psychological distress: an analysis of data from 2007 to 2016 Japanese national surveys. J Psychosoc Oncol Res Pract. 2020;2:e025. - PubMed
LinkOut - more resources
Full Text Sources